Storys zum Thema Krankheit

Technische Universität München

Coronavirus: door opener facilates cell entry

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36263/ NEWS RELEASE How the virus enters the cell Coronavirus: Neuropilin-1 could open the door to the inside of the cell The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including ...

Helmholtz Zentrum München

4

Novel medical imaging approach unlocks potential for improved diagnosis and interventions

Technische Universität München

Fighting corona with machine learning

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36254/ NEWS RELEASE The Bavarian Research Foundation is funding five TUM-research projects on Covid-19 Fighting corona with machine learning The Technical University of Munich (TUM) is starting five new research projects that focus on the ...

BrainRepair UG

Regulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan

Luoro GmbH

Revolutionary face mask can prevent cross-contamination

Solita

Finnish coronavirus tracing app Koronavilkku reaches 2 million downloads

Helsinki (ots) - The Finnish Koronavilkku ('Corona Blinker') application, which helps to break chains of coronavirus infection, has already been downloaded over 2 million times. The milestone of 2 million downloads - 37 % of the population - was reached two weeks after the application became available for download in app stores. 'We all now have a genuine opportunity ...

PAUL HARTMANN AG

HARTMANN launches Mission: Infection Prevention - how prevention is contagious

UMIT - The Health & Life Sciences University

University UMIT TIROL publishes the first population model to evaluate benefits and harms of universal salt iodization

Hall in Tirol (ots) - An article recently published by Schaffner and colleagues in the medical journal "Thyroid" summarizes the results of a decision-analytic population modeling study evaluating the benefits and harms of universal salt iodization. Iodine is a micronutrient that is essential for the production of ...

Sysmex Inostics GmbH

Sysmex Inostics' Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient Management

Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating cell-free tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study investigating the utility of cfDNA-based markers using the highly sensitive OncoBEAM RAS assay, an enhanced ...

Deutsche Post DHL Group

3

COVID-19-Impfstoffe: DHL-Studie gibt Auskunft für die erfolgreiche Zusammenarbeit zwischen öffentlichem und privatem Sektor/ Delivery of COVID-19 vaccine: DHL study shows how public and private sector can partner for success

Sysmex Inostics GmbH

Sysmex Inostics' OncoBEAMTM RAS CRC testing supports clinical outcome improvements for metastatic colorectal cancer patients rechallenged with anti-EGFR therapy

Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating RAS mutation status in circulating tumor DNA (ctDNA) of colorectal cancer (CRC) patients undergoing anti-EGFR ...

Carl Zeiss Meditec AG

Effectiveness and efficiency of targeted intra-operative single dose radiotherapy for breast cancer patients confirmed

Jena, Germany (ots) - New long-term results from the international TARGIT-A breast cancer study, based on ZEISS technology, have been published [1] Use of targeted intra-operative radiotherapy (TARGIT), as a single dose - with ZEISS INTRABEAM - directly after removal of a tumor, confirmed as non-inferior, when ...

Fördergesellschaft IZB mbH

KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Technische Universität München

Designed bacteria produce coral-antibiotic

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36204/ High resolution images: https://mediatum.ub.tum.de/1554685 NEWS RELEASE Sustainable biotechnological production of a natural substance against tuberculosis Designed bacteria produce coral-antibiotic Corals growing on the reefs of ...

Sysmex Inostics GmbH

Sysmex-Inostics Colorectal Cancer Blood-Based OncoBEAMTM RAS CE-IVD Test Shows Concordance with Standard of Care Tissue-Based RAS Testing

Baltimore, Maryland (ots) - Sysmex-Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating the performance of plasma RAS mutation testing with OncoBEAM RAS CRC as compared to standard of care ...

Dr. Rath Education Services BV

Micronutrient Combination Suppresses Cell 'Entry Door' For Coronavirus

Technische Universität München

Gut bacteria improve type 2 diabetes risk prediction

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36118/ Images for journalists: https://mediatum.ub.tum.de/1552269 NEWS RELEASE Large-scale study with more than 4000 participants at ZIEL - Institute for Food & Health Gut bacteria improve type 2 diabetes risk ...

Technische Universität München

Nutrition in the days of COVID

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36110/ Images for journalists: https://mediatum.ub.tum.de/1552085 NEWS RELEASE An interview with Prof. Hans Hauner about COVID-19 and nutritional medicine Nutrition in the days of COVID The current Corona outbreak affects nearly all aspects of medicine and of everyday ...

IgNova GmbH

IgNova files patent application on antibody against COVID-19

Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...

SYNformulas GmbH

2

Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation

eleva GmbH

Eleva's drug candidate to be examined for use in Covid-19 treatment

Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...

Technische Universität München

How to do sports during the Corona epidemic? - Interview with Prof. Henning Wackerhage on the interactions between sports and the coronavirus epidemic

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36046/ High resolution images: https://mediatum.ub.tum.de/1546898 NEWS RELEASE Sports and the corona ...

Technische Universität München

A disease trigger for pancreatitis has been identified

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36036/ High resolution images: https://mediatum.ub.tum.de/1545776 NEWS RELEASE A Calcium channel is involved in the development of pancreatitis A disease trigger for pancreatitis has been identified One factor ...

Technische Universität München

New x-ray method for Corona diagnosis ready for patient testing

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - e-mail: presse@tum.de - web: www.tum.de This news release online:https://www.tum.de/nc/en/about-tum/news/press-releases/details/36031/Images for editorial use:https://mediatum.ub.tum.de/1545412 NEWS RELEASE New x-ray method for Corona diagnosis ready for patient testing Low-dose ...

WSSCC

3

WSSCC approved to become the Sanitation and Hygiene Fund

Helmholtz Zentrum München

Nasal biomarkers predict severity of pollen-specific allergy symptoms

Nasal biomarkers predict severity of pollen-specific allergy symptoms It is not only people with allergies, but also a subgroup of people without one that suffer in spring and have nasal problems from contact with pollen. A new study shows that biomarkers in the nose can predict ...

Technische Universität München

Improving immunotherapy for cancer

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-5403 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36023/ High resolution images: https://mediatum.ub.tum.de/1544218 NEWS RELEASE Cause for the lack of immune defense against tumors discovered Improving immunotherapy for cancer One of the reasons why cancer develops is because regulatory cells inhibit the body's ...

Fielmann AG

Fielmann Family donates 3 million protective masks to German federal states / Private donation to the federal state governments of Brandenburg, Hamburg and Schleswig-Holstein

Hamburg (ots) - Fielmann has acted early and decidedly, as the coronavirus pandemic spread across Europe. On the basis of a scientific study by Prof. Dr. med. Dr. h.c. Martin Exner (University Hospital Bonn), the company has defined hygiene standards that counter the infection risks of COVID-19. According to these ...

Helmholtz Zentrum München

2

Beta cells from stem cells: Potential for cell replacement therapy

Technische Universität München

In the hunt for new treatments against the coronavirus

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-3207 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35999/ High resolution images: https://mediatum.ub.tum.de/1544195 In the hunt for new treatments against the coronavirus Researchers develop software for drug repurposing Currently, the corona pandemic is ...